ACIP Issues Adult Vaccination Schedule 2022 ACIP Issues Adult Vaccination Schedule 2022
Changes affect zoster, pneumococcal, and hepatitis B vaccines, and COVID-19 is now included.News Alerts (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 17, 2022 Category: Allergy & Immunology Tags: Internal Medicine News Alert Source Type: news
CDC Issues New Pneumococcal Vaccine Recommendations for Adults CDC Issues New Pneumococcal Vaccine Recommendations for Adults
The recommendations strive to streamline vaccination, improve uptake.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 1, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Recommendations Simplified for Pneumococcal Vaccination
ACIP recommends PCV20 alone or PCV15 in series with PPSV23 for all aged 65 years and older or younger adults at risk (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - January 28, 2022 Category: Respiratory Medicine Tags: Infections, Internal Medicine, Nursing, Pharmacy, Pulmonology, Geriatrics, Journal, Source Type: news
Recommendations Simplified for Pneumococcal Vaccination
THURSDAY, Jan. 27, 2022 -- A new policy has simplified the Advisory Committee on Immunization Practices (ACIP) pneumococcal vaccination recommendations; the updated recommendations are published in the Jan. 28 issue of the U.S. Centers for Disease... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
This report describes the Advisory Committee on Immunization Practice recommendations for administering the pneumococcal conjugate vaccine to U.S. adults. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 27, 2022 Category: American Health Tags: Adult Health Adult Vaccinations Advisory Committee on Immunization Practices (ACIP) MMWR Morbidity & Mortality Weekly Report Vaccine-Preventable Diseases and Specific Vaccines Pneumococcal Disease Source Type: news
The World ’s Largest Vaccine Manufacturer Stumbled in 2021. Its CEO Bets He Can Still Help End COVID-19
Adar Poonawalla is no stranger to gambles. He owes his multibillion-dollar empire to a series of big bets that paid off handsomely. Cyrus Poonawalla, his father, made his own fortune on horses—and then multiplied it by making another bet in 1966: that he could make more money producing vaccines than he could on horse breeding and racing. He formed the Serum Institute of India (SII), which grew slowly for three decades, selling antivenoms and lifesaving vaccines for India.
When Adar, then just 21, joined the company in 2001, he persuaded his father to dramatically ramp up production—wagering that they could fill...
Source: TIME: Health - January 20, 2022 Category: Consumer Health News Authors: Abhishyant Kidangoor Tags: Uncategorized biztech2030 COVID-19 Davos feature Magazine overnight Special Project Source Type: news
Nigeria: Taraba State Flags-Off Integrated Yellow Fever, Measles and Meningitis Vaccination Campaign
[WHO-AFRO] The National Primary Health Care and Development Agency (NPHCDA), World Health Organization (WHO), UNICEF, Gavi, the global vaccine alliance, and partners are working to boost population immunity against measles, meningitis, and yellow fever in 13 high-risk states. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 25, 2021 Category: African Health Source Type: news
Gates Foundation to invest up to $90M in vaccine maker Inventprise
Redmond-based vaccine maker Inventprise is gaining serious backing from the Bill& Melinda Gates Foundation.
On Wednesday, the biotech company announced an investment from the foundation of up to $90 million, contingent on manufacturing, clinical and preclinical milestones. The foundation is investing in IVT-25, a vaccine targeting pneumococcal bacterial infections. Pneumococcus can cause infections like pneumonia and meningitis.
"High rates of morbidity and mortality due to pneumococcal disease… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 10, 2021 Category: American Health Authors: Rick Morgan Source Type: news
Why You Should Vaccinate Your Kids Against COVID-19
It’s time for my healthy nine-year-old son to get vaccinated against COVID-19. In fact, it’s time for every kid aged five to eleven to get vaccinated.
An advisory committee to the Food and Drug Administration (FDA) has reviewed the data from clinical trials assessing the safety and efficacy of the Pfizer-BioNTech vaccine in children five to eleven years old. The experts voted unanimously to recommend authorization for this vaccine in children in that age range. As a next step, the Centers for Disease Control and Prevention (CDC) will decide whether all kids should have access to the vaccine, or only some. Some ...
Source: TIME: Health - October 30, 2021 Category: Consumer Health News Tags: Uncategorized COVID-19 Source Type: news
Upstate seeks volunteers for a study evaluating a new combination vaccine for the prevention of meningitis
Upstate is working with GlaxoSmithKline (GSK) to develop the new combination vaccine intended to protect against five of the most prevalent serogroups of the bacteria causing meningitis. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - October 27, 2021 Category: Universities & Medical Training Tags: News Source Type: news
ACIP Expands Shingrix Recs; Updates Pneumococcal Vax Guidance ACIP Expands Shingrix Recs; Updates Pneumococcal Vax Guidance
The committee voted to recommend that immunocompromised adults aged 19+ be vaccinated against shingles, and that adults with certain risk factors or aged 65 and older receive a pneumococcal vaccine.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - October 22, 2021 Category: Internal Medicine Tags: Infectious Diseases News Source Type: news
What Causes Irritability?
Discussion
Child abuse or non-accidental trauma is a clinical diagnosis. It is the constellation of history, physical examination, radiographic evaluation, laboratory testing and investigation that determines if child abuse has occurred. Irritability caused by fractures or other trauma can be a presenting symptom of abuse. Fractures can be a presentation but they are also common problems not associated with abuse. Femoral shaft fractures are estimated to account for only 1.6% of all fractures in children, therefore they are potentially more suspicious for child abuse. A review of femur fractures can be found here. A review...
Source: PediatricEducation.org - October 18, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
EMA Recommends VAXNEUVANCE Pneumococcal Vaccine for Approval EMA Recommends VAXNEUVANCE Pneumococcal Vaccine for Approval
The vaccine, which received FDA approval in July, protects against 15 strains of Streptococcus pneumoniae.International Approvals (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - October 15, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news
Vaccination Rates For Whooping Cough, HPV, Meningitis (And More) Plummeted During Covid Lockdown
Routine vaccinations fell across all age groups, according to a new study (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 7, 2021 Category: Pharmaceuticals Authors: Graison Dangor, Forbes Staff Tags: Healthcare /healthcare Innovation /innovation Breaking breaking-news Coronavirus Source Type: news
Pneumococcal vaccination reduces antibacterial failure and costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - October 1, 2021 Category: Drugs & Pharmacology Source Type: news
